Cite
HARVARD Citation
Satake, N. et al. (n.d.). Targeted therapy with MXD3 siRNA, anti‐CD22 antibody and nanoparticles for precursor B‐cell acute lymphoblastic leukaemia. British journal of haematology. pp. 487-499. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Satake, N. et al. (n.d.). Targeted therapy with MXD3 siRNA, anti‐CD22 antibody and nanoparticles for precursor B‐cell acute lymphoblastic leukaemia. British journal of haematology. pp. 487-499. [Online].